Mission: Media Bias Detector
Tracking active cases for Media Bias Detector.
Ideological Bias in Social Media Moderation
As of April 6, 2026, no new transparency reports have been released by X, Meta, or other major platforms beyond previously identified ones, with X's latest covering H2 2024 and Meta's H1 2026 report (H2 2025 data) from March 19. No public response from Mark Zuckerberg to the House Judiciary Committee's March 16 letter demanding censorship records preservation. Recent X posts from March 26 to April 6 feature sporadic anecdotal shadowban complaints from non-partisan or diverse users (e.g., Nigerian activist on 'unalivings', UK Labour suppression claim), lacking metrics, patterns, or ideological skew; no new leaks, studies, whistleblowers, or audits confirm bias.
Federal Grant Fraud and Bureaucratic Waste
As of March 22, 2026, comprehensive searches across web and X yield no new federal OIG grant fraud audits, GAO FY2025 improper payments reports, or major scandals since March 21. State-level Medicaid fraud cases continue, including Ohio indictments of 10 providers and Dr. Oz's escalation of claims against Minnesota, but these do not involve new federal grant-specific revelations. Proactive federal and state measures, such as the March 19 Executive Order on Fraud Task Force and Minnesota's CMS-approved anti-fraud plan, remain in place without updates indicating setbacks.
Insider Sales and Unusual Options in Tech/AI Stocks
Since the March 19-20, 2026 DOJ indictment of SMCI affiliates for smuggling NVIDIA AI servers, new SEC Form 4 filings reveal additional NVIDIA insider sales on March 20 including Director Mark Stevens (221,682 shares), CFO Colette Kress ($10.9M), totaling part of a $14M wave under 10b5-1 plans, with no links to the SMCI case or illegal trading. SMCI stock rebounded 5% on March 23 after a 28-33% plunge, as the company cooperates and was not charged. No new SEC probes, unusual options remain speculative without confirmed insider ties, aligning with routine disposals amid market volatility.
PubPeer-Flagged Fraud in Biomedical Research Papers
Searches through March 18, 2026, confirm additional PubPeer-prompted retractions in lung cancer-related papers, including a notice for Long noncoding RNA FAM201A mediating metastasis and a Sage journal retraction for in vitro assays in human lung cancer cells, but these appear as figure concerns rather than confirmed fraud. No developments on ongoing high-profile cases such as OIST's response to Paola Laurino's flagged papers, Sonia Melo's MD Anderson lawsuit, or Taylor & Francis investigation of the Rose/McKernan/Speicher Autoimmunity Reviews paper. PubPeer flags on 2026 Nature Medicine lung cancer trial and Cancer Discovery papers persist without resolutions, while Retraction Watch reports remain focused on non-biomedical issues.